Methylation of death-associated protein kinase is associated with cetuximab and erlotinib resistance.
Ogawa T; Liggett TE; Melnikov AA; Monitto CL; Kusuke D; Shiga K; Kobayashi T; Horii A; Chatterjee A; Levenson VV; Koch WM; Sidransky D; Chang X; Cell Cycle (Georgetown, Tex.), 2012, vol. 11, issue 8, p 1656, ISSN 15514005. ISBN 15514005.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef